5/29
08:14 am
dmac
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Low
Report
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
5/22
08:55 am
dmac
DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025 [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025 [Yahoo! Finance]
5/22
08:30 am
dmac
DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025
Low
Report
DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025
5/19
09:26 am
dmac
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia [Yahoo! Finance]
5/19
09:00 am
dmac
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
Low
Report
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
5/14
05:13 pm
dmac
DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025 [Yahoo! Finance]
Medium
Report
DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025 [Yahoo! Finance]
5/14
04:30 pm
dmac
DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025
Medium
Report
DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025
5/13
04:30 pm
dmac
DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights
Low
Report
DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights
5/8
04:00 pm
dmac
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May
Low
Report
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May
5/7
08:30 am
dmac
DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025
Low
Report
DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025
3/19
08:04 am
dmac
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its price target raised by analysts at HC Wainwright from $7.00 to $10.00. They now have a "buy" rating on the stock.
Neutral
Report
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its price target raised by analysts at HC Wainwright from $7.00 to $10.00. They now have a "buy" rating on the stock.
3/17
04:30 pm
dmac
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results
High
Report
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results
3/17
08:07 am
dmac
Insider Stock Buying Reaches US$9.00m On DiaMedica Therapeutics [Yahoo! Finance]
Medium
Report
Insider Stock Buying Reaches US$9.00m On DiaMedica Therapeutics [Yahoo! Finance]